Cellyan Biotechnology (HKPD) Enterprise Value (2024 - 2026)
Cellyan Biotechnology (HKPD) posted quarterly Enterprise Value of -$3.0 million for Q3 2025, down 384.27% year-over-year from $1.1 million in Q3 2024, and down 1.13% quarter-over-quarter from -$3.0 million in Q1 2025.
Cellyan Biotechnology (HKPD) Enterprise Value (2024 - 2026) Analysis & Trends
Cellyan Biotechnology (HKPD) has reported Enterprise Value for 2 consecutive years, with -$3.0 million the latest figure, recorded in Q3 2025.
- In Q3 2025, Enterprise Value fell 384.27% year-over-year to -$3.0 million; the TTM figure through Sep 2025 stood at -$3.0 million (down 384.27% YoY), while the FY2025 annual figure was -$3.0 million, down 373.36% from the prior year.
- Enterprise Value declined to -$3.0 million in Q3 2025 per HKPD's latest filing, from -$3.0 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$627658.0 in Q3 2024 and bottomed at -$3.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Mckesson | 102.18 Bn | 97.02 Bn | 3.69 Bn | -2.60 Bn |
| 2 | Cencora | 61.45 Bn | 58.64 Bn | 3.61 Bn | -2.63 Bn |
| 3 | Cardinal Health | 54.05 Bn | 49.19 Bn | 2.56 Bn | -4.70 Bn |
| 4 | Henry Schein | 10.04 Bn | 9.88 Bn | 1.10 Bn | 749.00 Mn |
| 5 | Akso Health | 676.38 Mn | 676.18 Mn | - | -212,233.00 |
| 6 | Edap Tms | 156.49 Mn | 134.95 Mn | 7.34 Mn | -21.54 Mn |
| 7 | Accendra Health | 92.03 Mn | 84.38 Mn | 263.41 Mn | -7.65 Mn |
| 8 | 111 | 30.17 Mn | -28.59 Mn | 18.18 Mn | 78.52 Mn |
| 9 | Cosmos Health | 13.17 Mn | 10.72 Mn | 1.51 Mn | -2.45 Mn |
| 10 | Cellyan Biotechnology | 6.61 Mn | 6.38 Mn | - | -221,841.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -458,714.00 |
| Sep 30, 2025 | -3.04 Mn |
| Mar 31, 2025 | -3.01 Mn |
| Sep 30, 2024 | -627,658.00 |
| Mar 31, 2024 | -634,939.00 |